CPF · Central Pacific Financial Corp

2026 BOD Fees (covering the period 5/1/26-4/30/27) issued in CPF Stock. The 2026 Board fees were approved by the Board Compensation Committee in October 2025.

2022 BOD Fees issued in CPF shares held in the Director's Deferred Comp Plan as phantom stock. Each phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in cash after the Director's termination of service.

2026 BOD Fees (covering the period 5/1/26-4/30/27) issued in CPF shares held in the Director's Deferred Comp Plan as phantom stock. Each phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in cash after the Director's termination of service. The 2026 Board fees were approved by the Board Compensation Committee in October 2025.

2026 BOD Fees (covering the period 5/1/26-4/30/27) issued in CPF Stock. The 2026 Board fees were approved by the Board Compensation Committee in October 2025.

2022 BOD Fees issued in CPF shares held in the Director's Deferred Comp Plan as phantom stock. Each phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in cash after the Director's termination of service.

2026 BOD Fees (covering the period 5/1/26-4/30/27) issued in CPF shares held in the Director's Deferred Comp Plan as phantom stock. Each phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in cash after the Director's termination of service. The 2026 Board fees were approved by the Board Compensation Committee in October 2025.

2026 BOD Fees (covering the period 5/1/26-4/30/27) issued in CPF Stock. The 2026 Board fees were approved by the Board Compensation Committee in October 2025.

2026 BOD Fees (covering the period 5/1/26-4/30/27) issued in CPF Stock. The 2026 Board fees were approved by the Board Compensation Committee in October 2025.

2026 BOD Fees (covering the period 5/1/26-4/30/27) issued in CPF Stock. The 2026 Board fees were approved by the Board Compensation Committee in October 2025.

2022 BOD Fees issued in CPF shares held in the Director's Deferred Comp Plan as phantom stock. Each phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in cash after the Director's termination of service.

2026 BOD Fees (covering the period 5/1/26-4/30/27) issued in CPF shares held in the Director's Deferred Comp Plan as phantom stock. Each phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in cash after the Director's termination of service. The 2026 Board fees were approved by the Board Compensation Committee in October 2025.

2026 BOD Fees (covering the period 5/1/26-4/30/27) issued in CPF Stock. The 2026 Board fees were approved by the Board Compensation Committee in October 2025.

2/17/26 RSU Grant. Shares vest evenly over 3 years.

2/15/24 RSU Grant. Shares vest evenly over 3 years. Outstanding shares vest in 2 remaining tranches.

Shares used for taxes on vested shares

2/15/23 PSU Grant that cliff vests on 2/15/26 (next business day if 2/15 falls on weekend/holiday) based on performance results/approval. The Board Compensation Committee reviewed and certified final performance results on 2/23/26. Amount reported is the actual number of shares that vested and were issued.

2/18/25 RSU Grant. Shares vest evenly over 3 years.

Shares used for taxes on vested shares

2/17/26 RSU Grant. Shares vest evenly over 3 years.

2/15/23 PSU Grant that cliff vests on 2/15/26 (next business day if 2/15 falls on weekend/holiday) based on performance results/approval. The Board Compensation Committee reviewed and certified final performance results on 2/23/26. Amount reported is the actual number of shares that vested and were issued.

Shares used for taxes on vested shares

2/18/25 RSU Grant. Shares vest evenly over 3 years.

Shares used for taxes on vested shares

2/15/23 PSU Grant that cliff vests on 2/15/26 (next business day if 2/15 falls on weekend/holiday) based on performance results/approval. The Board Compensation Committee reviewed and certified final performance results on 2/23/26. Amount reported is the actual number of shares that vested and were issued.

Shares used for taxes on vested shares

2/18/25 RSU Grant. Shares vest evenly over 3 years.

Shares used for taxes on vested shares

2/15/24 RSU Grant. Shares vest evenly over 3 years.

Shares used for taxes on vested shares

2/15/24 RSU Grant. Shares vest evenly over 3 years.

Shares used for taxes on vested shares

2/15/23 RSU Time-Based Grant. Shares vest evenly over 3 years

Shares used for taxes on vested shares

2/15/23 PSU Grant that cliff vests on 2/15/26 (next business day if 2/15 falls on weekend/holiday) based on performance results/approval. The Board Compensation Committee reviewed and certified final performance results on 2/23/26. Amount reported is the actual number of shares that vested and were issued.

Shares used for taxes on vested shares

2/18/25 RSU Grant. Shares vest evenly over 3 years.

Shares used for taxes on vested shares

2/15/23 PSU Grant that cliff vests on 2/15/26 (next business day if 2/15 falls on weekend/holiday) based on performance results/approval. The Board Compensation Committee reviewed and certified final performance results on 2/23/26. Amount reported is the actual number of shares that vested and were issued.

2/15/23 RSU Grant. Shares vest evenly over 3 years. Outstanding shares vest in 1 remaining tranche

Shares used for taxes on vested shares

2/17/26 RSU Grant. Shares vest evenly over 3 years.

2/15/23 RSU Time-Based Grant. Shares vest evenly over 3 years

Shares used for taxes on vested shares

2/15/23 PSU Grant that cliff vests on 2/15/26 (next business day if 2/15 falls on weekend/holiday) based on performance results/approval. The Board Compensation Committee reviewed and certified final performance results on 2/23/26. Amount reported is the actual number of shares that vested and were issued.

This transaction was effected pursuant to a Rule 10b5-1 Plan entered into by the reporting person on February 3, 2025. Accordingly, the reporting person had no discretion with regard to the timing of the transaction.

Represents the weighted average purchase price. The shares were purchased at prices ranging from $30.44 to $30.83 per share. Full information regarding the number of shares purchased at each price shall be provided to the Securities and Exchange Commission staff (the "Staff"), Issuer, or a security holder of Issuer, upon request.

Charitable gift of shares to a Donor Advised Fund

This transaction was effected pursuant to a Rule 10b5-1 Plan entered into by the reporting person on February 3, 2025. Accordingly, the reporting person had no discretion with regard to the timing of the transaction.

Represents the weighted average purchase price. The shares were purchased at prices ranging from $27.22 to $28.14 per share. Full information regarding the number of shares purchased at each price shall be provided to the Securities and Exchange Commission staff (the "Staff"), Issuer, or a security holder of Issuer, upon request.

This transaction was effected pursuant to a Rule 10b5-1 Plan entered into by the reporting person on March 5, 2025. Accordingly, the reporting person had no discretion with regard to the timing of the transaction.

Shares gifted to AUW

This transaction was effected pursuant to a Rule 10b5-1 Plan entered into by the reporting person on February 3, 2025. Accordingly, the reporting person had no discretion with regard to the timing of the transaction.

Represents the weighted average purchase price. The shares were purchased at prices ranging from $28.39 to $29.36 per share. Full information regarding the number of shares purchased at each price shall be provided to the Securities and Exchange Commission staff (the "Staff"), Issuer, or a security holder of Issuer, upon request.

This transaction was effected pursuant to a Rule 10b5-1 Plan entered into by the reporting person on March 5, 2025. Accordingly, the reporting person had no discretion with regard to the timing of the transaction.

This transaction was effected pursuant to a Rule 10b5-1 Plan entered into by the reporting person on February 3, 2025. Accordingly, the reporting person had no discretion with regard to the timing of the transaction.

Represents the weighted average purchase price. The shares were purchased at prices ranging from $26.435 to $27.36 per share. Full information regarding the number of shares purchased at each price shall be provided to the Securities and Exchange Commission staff (the "Staff"), Issuer, or a security holder of Issuer, upon request.

This transaction was effected pursuant to a Rule 10b5-1 Plan entered into by the reporting person on March 5, 2025. Accordingly, the reporting person had no discretion with regard to the timing of the transaction.

2025 BOD Fees (covering the period 5/1/25-4/30/26) issued in CPF Stock. The 2025 Board fees were approved by the Board Compensation Committee in October 2024.

2022 BOD Fees issued in CPF shares held in the Director's Deferred Comp Plan as phantom stock. Each phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in cash after the Director's termination of service.

2025 BOD Fees (covering the period 5/1/25-4/30/26) issued in CPF shares held in the Director's Deferred Comp Plan as phantom stock. Each phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in cash after the Director's termination of service. The 2025 Board fees were approved by the Board Compensation Committee in October 2024.

2025 BOD Fees (covering the period 5/1/25-4/30/26) issued in CPF Stock. The 2025 Board fees were approved by the Board Compensation Committee in October 2024.

2025 BOD Fees (covering the period 5/1/25-4/30/26) issued in CPF Stock. The 2025 Board fees were approved by the Board Compensation Committee in October 2024.

2025 BOD Fees (covering the period 5/1/25-4/30/26) issued in CPF Stock. The 2025 Board fees were approved by the Board Compensation Committee in October 2024.

2022 BOD Fees issued in CPF shares held in the Director's Deferred Comp Plan as phantom stock. Each phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in cash after the Director's termination of service.

2025 BOD Fees (covering the period 5/1/25-4/30/26) issued in CPF shares held in the Director's Deferred Comp Plan as phantom stock. Each phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in cash after the Director's termination of service. The 2025 Board fees were approved by the Board Compensation Committee in October 2024.

2025 BOD Fees (covering the period 5/1/25-4/30/26) issued in CPF Stock. The 2025 Board fees were approved by the Board Compensation Committee in October 2024.

CPF Stock Holding on 1/1/2023

2025 BOD Fees (covering the period 5/1/25-4/30/26) issued in CPF Stock. The 2025 Board fees were approved by the Board Compensation Committee in October 2024.

2025 BOD Fees (covering the period 5/1/25-4/30/26) issued in CPF Stock. The 2025 Board fees were approved by the Board Compensation Committee in October 2024.